Middle Molecule Find

Rulebook › V-tags › V258

V258 Endotoxin test: sample and positive control tubes

Written V0258 on the CMS-2567 and in QCOR.

Enforces ANSI/AAMI RD52:2004, adopted by reference at 42 CFR 494.40(a) · Appendix H Rev. 246, page 122 · checked 12 Nov 2026

Cited on this tag? What happens after a citation · One-page sheet for the binder

The regulation

ANSI/AAMI RD52:2004 Requirements as Adopted by Reference 42 CFR 494.40(a)

7.2.4 Bacterial endotoxin test

At a minimum, two tubes should be run each time the assay is performed. The first tube contains LAL reagent and the sample to be tested. The second tube contains LAL reagent, a known amount of endotoxin, and the sample to be tested. The second tube acts as a positive control to confirm the absence of any interference that might lead to a false negative result.

CMS's interpretive guidance

Interpretive Guidance § 494.40(a)

ANSI/AAMI RD52:2004

7.2.4 Bacterial endotoxin test

Bacterial endotoxin testing is done using the Limulus amoebocyte lysate (LAL) assay. Two basic types of assay can be performed. The first is a kinetic assay, which is available in a colorimetric or turbidimetric format, and the second is a gel-clot assay.

The kinetic LAL assay uses control standard endotoxin to generate a standard curve to which unknowns are compared and concentrations are determined using linear regression. The kinetic assays employed in laboratories generally use a computer-driven spectrophotometer that automatically calculates the amount of endotoxin on the basis of color development or onset times for gel formation.

The gel-clot LAL assay is not as sensitive as the kinetic assay and provides only a positive or negative result; that is, it shows if endotoxin is present—or not—at a particular concentration. Single tube gel-clot tubes are available from several commercial sources, and kits with the following sensitivities are currently available:
0.015 EU, 0.03 EU, 0.06 EU, 0.125 EU, 0.25 EU, and 0.5 EU. Please note that these availabilities are subject to change, as technologies for testing sensitivities advance with time.

Positive control tubes are available from the suppliers of commercial LAL assays. More sophisticated testing protocols involving reagent controls may also be used (see 2.7), but their use is optional in this application.

Additional Guidance:

Technology for endotoxin testing is evolving and these regulations are not meant to prevent the use of a newer testing methodology, once such methodology is approved by FDA.

Verbatim from Appendix H Rev. 246, with CMS's headings, lists and bold. Check page 122 (the full 469-page PDF) before quoting it.